These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 25416559)

  • 1. CYP2A6 reduced activity gene variants confer reduction in lung cancer risk in African American smokers--findings from two independent populations.
    Wassenaar CA; Ye Y; Cai Q; Aldrich MC; Knight J; Spitz MR; Wu X; Blot WJ; Tyndale RF
    Carcinogenesis; 2015 Jan; 36(1):99-103. PubMed ID: 25416559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYP2A6 genetic polymorphisms and biomarkers of tobacco smoke constituents in relation to risk of lung cancer in the Singapore Chinese Health Study.
    Yuan JM; Nelson HH; Carmella SG; Wang R; Kuriger-Laber J; Jin A; Adams-Haduch J; Hecht SS; Koh WP; Murphy SE
    Carcinogenesis; 2017 Apr; 38(4):411-418. PubMed ID: 28182203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CYP2A6 genetic polymorphism is associated with decreased susceptibility to squamous cell lung cancer in Japanese smokers.
    Hosono H; Kumondai M; Arai T; Sugimura H; Sasaki T; Hirasawa N; Hiratsuka M
    Drug Metab Pharmacokinet; 2015 Aug; 30(4):263-8. PubMed ID: 26091970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transferability of Ancestry-Specific and Cross-Ancestry CYP2A6 Activity Genetic Risk Scores in African and European Populations.
    El-Boraie A; Chenoweth MJ; Pouget JG; Benowitz NL; Fukunaga K; Mushiroda T; Kubo M; Nollen NL; Sanderson Cox L; Lerman C; Knight J; Tyndale RF
    Clin Pharmacol Ther; 2021 Oct; 110(4):975-985. PubMed ID: 33300144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic determinants of cytochrome P450 2A6 activity and biomarkers of tobacco smoke exposure in relation to risk of lung cancer development in the Shanghai cohort study.
    Yuan JM; Nelson HH; Butler LM; Carmella SG; Wang R; Kuriger-Laber JK; Adams-Haduch J; Hecht SS; Gao YT; Murphy SE
    Int J Cancer; 2016 May; 138(9):2161-71. PubMed ID: 26662855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of CYP2A6 activity with lung cancer incidence in smokers: The multiethnic cohort study.
    Park SL; Murphy SE; Wilkens LR; Stram DO; Hecht SS; Le Marchand L
    PLoS One; 2017; 12(5):e0178435. PubMed ID: 28542511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries.
    Baurley JW; Edlund CK; Pardamean CI; Conti DV; Krasnow R; Javitz HS; Hops H; Swan GE; Benowitz NL; Bergen AW
    Nicotine Tob Res; 2016 Sep; 18(9):1837-1844. PubMed ID: 27113016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity.
    Benowitz NL; St Helen G; Dempsey DA; Jacob P; Tyndale RF
    Pharmacogenet Genomics; 2016 Jul; 26(7):340-50. PubMed ID: 27035242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic determinants of CYP2A6 activity across racial/ethnic groups with different risks of lung cancer and effect on their smoking intensity.
    Park SL; Tiirikainen MI; Patel YM; Wilkens LR; Stram DO; Le Marchand L; Murphy SE
    Carcinogenesis; 2016 Mar; 37(3):269-279. PubMed ID: 26818358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency of CYP2A6 gene deletion and its relation to risk of lung and esophageal cancer in the Chinese population.
    Tan W; Chen GF; Xing DY; Song CY; Kadlubar FF; Lin DX
    Int J Cancer; 2001 Mar; 95(2):96-101. PubMed ID: 11241319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in CYP2A6 and nicotine metabolism among two American Indian tribal groups differing in smoking patterns and risk for tobacco-related cancer.
    Tanner JA; Henderson JA; Buchwald D; Howard BV; Nez Henderson P; Tyndale RF
    Pharmacogenet Genomics; 2017 May; 27(5):169-178. PubMed ID: 28181923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism of CYP2A6 gene and tobacco-induced lung cancer risk in male smokers.
    Ariyoshi N; Miyamoto M; Umetsu Y; Kunitoh H; Dosaka-Akita H; Sawamura Y; Yokota J; Nemoto N; Sato K; Kamataki T
    Cancer Epidemiol Biomarkers Prev; 2002 Sep; 11(9):890-4. PubMed ID: 12223434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences.
    Chenoweth MJ; Ware JJ; Zhu AZX; Cole CB; Cox LS; Nollen N; Ahluwalia JS; Benowitz NL; Schnoll RA; Hawk LW; Cinciripini PM; George TP; Lerman C; Knight J; Tyndale RF;
    Addiction; 2018 Mar; 113(3):509-523. PubMed ID: 28921760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphism of CYP2D6 and lung cancer risk in African-Americans and Caucasians in Los Angeles County.
    London SJ; Daly AK; Leathart JB; Navidi WC; Carpenter CC; Idle JR
    Carcinogenesis; 1997 Jun; 18(6):1203-14. PubMed ID: 9214604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Admixture mapping of lung cancer in 1812 African-Americans.
    Schwartz AG; Wenzlaff AS; Bock CH; Ruterbusch JJ; Chen W; Cote ML; Artis AS; Van Dyke AL; Land SJ; Harris CC; Pine SR; Spitz MR; Amos CI; Levin AM; McKeigue PM
    Carcinogenesis; 2011 Mar; 32(3):312-7. PubMed ID: 21115650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium.
    Truong T; Hung RJ; Amos CI; Wu X; Bickeböller H; Rosenberger A; Sauter W; Illig T; Wichmann HE; Risch A; Dienemann H; Kaaks R; Yang P; Jiang R; Wiencke JK; Wrensch M; Hansen H; Kelsey KT; Matsuo K; Tajima K; Schwartz AG; Wenzlaff A; Seow A; Ying C; Staratschek-Jox A; Nürnberg P; Stoelben E; Wolf J; Lazarus P; Muscat JE; Gallagher CJ; Zienolddiny S; Haugen A; van der Heijden HF; Kiemeney LA; Isla D; Mayordomo JI; Rafnar T; Stefansson K; Zhang ZF; Chang SC; Kim JH; Hong YC; Duell EJ; Andrew AS; Lejbkowicz F; Rennert G; Müller H; Brenner H; Le Marchand L; Benhamou S; Bouchardy C; Teare MD; Xue X; McLaughlin J; Liu G; McKay JD; Brennan P; Spitz MR
    J Natl Cancer Inst; 2010 Jul; 102(13):959-71. PubMed ID: 20548021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK.
    Wang H; Tan W; Hao B; Miao X; Zhou G; He F; Lin D
    Cancer Res; 2003 Nov; 63(22):8057-61. PubMed ID: 14633739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of CYP2A6 genetic polymorphisms as determinants of smoking behavior and tobacco-related lung cancer risk in male Japanese smokers.
    Fujieda M; Yamazaki H; Saito T; Kiyotani K; Gyamfi MA; Sakurai M; Dosaka-Akita H; Sawamura Y; Yokota J; Kunitoh H; Kamataki T
    Carcinogenesis; 2004 Dec; 25(12):2451-8. PubMed ID: 15308589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethnic differences in poly(ADP-ribose) polymerase pseudogene genotype distribution and association with lung cancer risk.
    Gu J; Spitz MR; Yang F; Wu X
    Carcinogenesis; 1999 Aug; 20(8):1465-9. PubMed ID: 10426793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between CYP2A6 and CHRNA5-CHRNA3-CHRNB4 variation and smoking behaviors and lung cancer risk.
    Wassenaar CA; Dong Q; Wei Q; Amos CI; Spitz MR; Tyndale RF
    J Natl Cancer Inst; 2011 Sep; 103(17):1342-6. PubMed ID: 21747048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.